The largest database of trusted experimental protocols

8 protocols using carbachol

1

Carbachol-Induced VSMC Contractility Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSC-VSMCs or primary VSMCs cultured in maturation medium were treated with 1 mM carbachol (Abcam) or PBS (vehicle control) for 20 min. Images of the cell morphology were taken before and after the treatment. Changes of surface area were analyzed using ImageJ. Three independent batches of cells were used to perform the contractility assay for each treatment, and 10 cells were randomly selected in each batch for each treatment for analyzing the changes in surface area.
+ Open protocol
+ Expand
2

Colorimetric Assay of Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The water-soluble tetrazolium-1 (WST-1) assay kit (Roche Diagnostics GmbH, Germany) was used to determine the viability of LIM-2405 and HT-29 cells. WST-1 is cleaved to form formazan dye via a complex cellular interaction at the cell surface. This interaction is contingent on the viable cells’ production of glycolytic nicotinamide adenine dinucleotide phosphate (NADPH). Hence, the amount of formed formazan dye correlates with the number of viable cells in the culture. LIM-2405 and HT-29 cells were seeded and cultured at 1 × 104 cells per well in 96-well plates for 24 h (hrs). Cells were then treated with various concentrations of the general muscarinic receptor blocker, atropine (Sigma-Aldrich, Australia) for 1–48 h, selective M3R blocker, 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP) (Abcam, Australia), cholinergic agonist, carbachol (Abcam, Australia) and acetylcholinesterase inhibitor, donepezil (Abcam, Australia) for 8 h. All treatments were performed in triplicates, and three independent experiments were conducted. WST-1 reagent (10 µL) was added to each well and incubated at 37 °C for 1 h. Cellular proliferation at the absorbance of 450 nm was measured using a microplate reader (Varioskan Flash, Thermo Scientific, Australia).
+ Open protocol
+ Expand
3

Acute DRG Calcium Imaging Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Acute intact DRG preparations were prepared from GFAP-Cre::GCaMP6f mice. Briefly, vertebras and dura mater were removed and lumbar L4 and L5 DRGs were exposed and immediately covered with ice cold (slushy) incubation ACSF solution (95 mM NaCl, 1.9 mM KCl, 1.2 mM KH2PO4, 0.5 mM CaCl2, 7 mM MgSO4, 26 mM NaHCO3, 15 mM glucose, 50 mM sucrose) and bubbled with 95% O2 and 5% CO2. DRGs were incubated for 30 min at 35°C in the incubation solution and then left to recover for 1 h 30 min at room temperature. A single DRG was placed in the recording chamber of a custom-built 2-photon laser-scanning microscope with a 20x water immersion objective (x20/0.95w XLMPlanFluor, Olympus). GCaMP6f was excited at 920 nm with a Ti:Sapphire laser (Mai Tai HP; Spectra-Physics). DRGs were continuously superfused at a rate of 4 ml/min with recording solution (127 mM NaCl, 1.9 mM KCl, 1.2 mM KH2PO4, 2.4 mM CaCl2, 1.3 mM MgSO4, 26 mM NaHCO3, 15 mM glucose) and bubbled with 95% O2–5% CO2. To evoke intracellular Ca2+ elevations in DRG GCaMP6f-expressing cells, a cocktail of agonists to endogenous Gq GPCRs containing 50 μM DHPG (Abcam), 10 μM histamine (Sigma Aldrich), 10 μM carbachol (Abcam), and 50 μM ATP (Sigma Aldrich) was bath applied for 30 sec.
+ Open protocol
+ Expand
4

Contractility Assay of Vascular Smooth Muscle Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSC-VSMCs or human primary VSMCs cultured in either SmGM-2 medium, maturation medium (1% [v/v] FBS with 1 ng/ml TGF-β1 [Peprotech]), or TEVG medium (DMEM medium supplemented with 20% [v/v] FBS, 50 μg/mL ascorbic acid [Sigma-Aldrich], 50 μg/mL proline [Sigma-Aldrich], 20 μg/mL alanine [Sigma-Aldrich], 50 μg/mL glycine [Sigma-Aldrich], 3 ng/mL CuSO4 [Sigma-Aldrich], 0.13 U/mL human insulin [Sigma-Aldrich], 100 U/mL Penicillin G [Sigma-Aldrich] and 1 ng/mL TGF-β1 [Peprotech]) were treated with 1 mM carbachol (Abcam) or PBS (vehicle control) as a control for 20 minutes. Cell surface areas were recorded at the beginning and the end of the treatment. The changes of surface area were evaluated with the ImageJ software. Three independent batches of hiPSC-VSMCs or primary VSMCs were used in the contractility assay, and the changes in surface area of 10 randomly selected cells in each batch were recorded and analyzed, respectively.
+ Open protocol
+ Expand
5

Cholinergic Receptor Pharmacology Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carbachol was purchased from Abcam (Cambridge, MA). Pilocarpine, methylatropine bromide, and ATP were purchased from Sigma-Aldrich (St. Louis, MO). Atropine sulfate monohydrate was purchased from Alfa Aesar (Ward Hill, MA). Thapsigargin was purchased from Tocris Bioscience (Minneapolis, MN).
+ Open protocol
+ Expand
6

Evaluating Cholinergic Modulation in CT-26 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The water-soluble tetrazolium-1 (WST-1) assay kit (Roche Diagnostics GmbH, Penzberg, Germany) was used to determine the viability of CT-26 cells. WST-1 is cleaved to form formazan dye via a complex cellular interaction at the cell surface. This interaction is contingent on the viable cells’ production of glycolytic nicotinamide adenine dinucleotide phosphate (NADPH). Hence, the formed formazan dye correlates to the number of viable cells in the culture. CT-26 cells were seeded and cultured at 1 × 104 cells per well in 96 well plates for 24 h. Cells were then treated with various concentrations of the general muscarinic receptor blocker, atropine (Sigma-Aldrich, Australia), selective M3R blocker, 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP) (Abcam, Adelaide, SA, Australia), cholinergic agonist, carbachol (Abcam, Australia) and acetylcholinesterase inhibitor, donepezil (Abcam, Australia) for 8 h. All treatments were performed in triplicates, and three independent experiments were conducted. WST-1 reagent (10 µL) was added to each well and incubated at 37 °C for 1 h. Cellular proliferation at the absorbance of 450 nm was measured using a microplate reader (Varioskan Flash, Thermo Fisher Scientific, Scoresby, VIC, Australia).
+ Open protocol
+ Expand
7

Contractility Assay for siPSC-VSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
siPSC-VSMCs or swine primary VSMCs in growth medium or maturation medium were treated with 1 mM carbachol (Abcam) or 80 mM KCl (SigmaAldrich) or PBS as control for 30 minutes. Reduction of cell surface area was recorded as series of time-lapse images (images taken every 6 seconds). The changes of surface area were analyzed with ImageJ software. Three independent batches of siPSC-VSMCs or primary VSMCs were subjected to contractility assay for each treatment, and the surface area changes of 10 randomly selected siPSC-VSMCs in each batch for each treatment were recorded and analyzed, respectively.
+ Open protocol
+ Expand
8

Calcium Signaling Assay in HEK293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NF157, MRS2500, suramin, AR-C 118925XX, CGS15943, pertussis toxin (PTX), ATP, and ATPγS were from Tocris Bioscience (Bristol, UK). YM-254890 (YM) was from Wako Pure Chemical Industries (Richmond, VA). Bovine serum albumin (BSA) fraction V fatty acid-free was from Roche (Basel, Switzerland). Poly-d-lysine and apyrase were from Sigma-Aldrich (St. Louis, MO). Carbachol was from Abcam (Cambridge, UK). Triton X-100 was from Polysciences (Warrington, PA). RANTES was from Peprotech (Rocky Hill, NJ) and RANTES analog, PSC-RANTES was a gift from Oliver Hartley (Université de Genève). HEK293T cells were from American Type Culture Collection (ATCC) (Manassas, VA). Dulbecco’s Modified Eagle’s Medium GlutaMAX (DMEM), FluoroBrite DMEM, Dulbecco’s phosphate-buffered saline without Ca2+ and Mg2+ (DPBS), Hanks' Balanced Salt solution (HBSS), and HEPES buffer were from Fisher Scientific (Hampton, NH). Lipofectamine 2000 and trypsin–EDTA (0.25%, phenol red) were from ThermoFisher Scientific (Waltham, MA). Fetal bovine serum (FBS) was from Gemini Bio-Products (West Sacramento, CA). Clear and clear-bottom black 384-well microplates were from Greiner (Monroe, NC). FLIPR Calcium 6 Assay and Flexstation II 384 Plate Reader were from Molecular Devices (San Jose, CA). 384-well transfer tips for the Flexstation were from Axygen (Union City, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!